Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07671040Completed
Randomised, single-blind trial in schizophrenia (2 arms), sponsored by Hasanuddin University. Primary endpoints: Montreal Cognitive Assessment - Indonesian version at 12 weeks and High-Sensitivity C-Reactive Protein at 12 weeks. Started Mar 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07671040.